Examples of using P value in English and their translations into German
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Ecclesiastic
-
Political
-
Computer
-
Programming
-
Official/political
-
Political
P value one-sided.
Hazard Ratio P Value.
P value two-sided.
Nominal P value log rank.
Maintenance 5 mg/ kg(n=113) p value.
Information on the P value The P value is 0.00455.
P value for Standard Dose versus Low Dose comparison.
Treatment difference P value 95% CI.
P values based on Fisher's exact test to compare pegloticase versus placebo.
ARIP IMD 50/25 mg: p value< 0.0001.
Many multiple comparisons test are accompanied by confidence intervals and multiplicity adjusted P values.
Combined nomemclatura. P Value in Mio ECU.
As a general rule, if your“p value is at least five percent, your results are considered statistically significant.
Treatment with BRINAVESS effectively converted atrial fibrillation to sinus rhythm 47.0% BRINAVESS,14.0% placebo; P value 0.0001.
HBeAg Seroconversion*p value vs lamivudine< 0.05 a.
In patients given immediate Rituxan/MabThera followed by maintenance,the median of these parameters was significantly longer p value of.
A value below 1 in combination with a P value below 0.025 indicates superiority of len/dex over placebo/dex b.
Retinetion of verbal information wasfound improved to a statistically significant degree most P values better than 0.01, some better than 0.001.
Key: QM once monthly, a nominal p value< 0.001 when compared with placebo, b p value< 0.001 when compared with placebo.
The study showed significant improvement in PFS for patients in the Kd arm over those in the Vd arm(HR: 0.53, 95% CI: 0.44,0.65[p value 0.0001]) see figure 3.
Non-significant p value after adjustment for 2 interim analyses on the primary efficacy comparison from a log-rank analysis stratified by smoking status.
In this case, because bothcommands run in the same session, the commands succeed, and the$p value remains active in the$s session for later use.
The interaction P values between the lowest mean arterial pressure(MAP) and baseline were< 0.001 and 0.84 between the lowest% MAP decrease and baseline, respectively.
Key: HoFH homozygous familial hypercholesterolaemia; QM once monthly;a nominal p value< 0.001 when compared with placebo; b p value< 0.001 when compared with placebo.
The regimen 3 mg/kg/day during 6 months(selected at the end of the phase II part ofthe study) presented 60.4% of success versus 3.6% in the placebo arm p value< 0.0001.
Key: Q2W once every 2 weeks, QM once monthly,HMD Primary hypercholesterolaemia and mixed dyslipidaemia, a p value< 0.05 when compared with ezetimibe, b p value< 0.001 when compared with ezetimibe, c nominal p value< 0.001 when compared with ezetimibe.
The prespecified net clinical benefit(primary efficacy outcome plus major bleeding events) was reported with a hazard ratio of 0.67((95% CI: 0.47- 0.95),nominal p value p=0.027) in favour of rivaroxaban.
Key: Q2W once every 2 weeks, QM once monthly, HMD Primary hypercholesterolaemia and mixed dyslipidaemia;HeFH Heterozygous familial hypercholesterolaemia; a p value< 0.05 when compared with placebo. b p value< 0.001 when compared with placebo.
Drop outs due to reasons other than treatment failure were censored at the time of dropping out. a HR of adalimumab vs placebo from proportional hazards regression with treatment as factor.b 2-sided P value from log rank test. c NE not estimable.
The silicone compounds were only tested for static seal, therefore he values are to be considered in relation to the blowing percentage of the compound: C indicates values less than 10%;S values falling between 10% and 30%; P values close to 30%; N unacceptable blowing values. .